MDL | MFCD00002741 |
---|---|
Molecular Weight | 214.34 |
Molecular Formula | C13H26O2 |
SMILES | CCCCCCCCCCCCC(O)=O |
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT03059160 | Sheba Medical Center|Ultragenyx Pharmaceutical Inc |
Rett Syndrome
|
April 1, 2017 | Phase 2 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 100 mg/mL ( 466.55 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 4.6655 mL | 23.3274 mL | 46.6548 mL |
5 mM | 0.9331 mL | 4.6655 mL | 9.3310 mL |
10 mM | 0.4665 mL | 2.3327 mL | 4.6655 mL |